HR 2344
117th Congress
House
Health
Criminal justice information and records
Drug trafficking and controlled substances
Health information and medical records
Health personnel
Intergovernmental relations
Licensing and registrations
Medical ethics
Prescription drugs
State and local government operations
Prescription Drug Monitoring Act of 2021
Introduced: April 1, 2021
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 2, 2021
Referred to the Subcommittee on Health.
Apr 1, 2021
Referred to the House Committee on Energy and Commerce.
Apr 1, 2021
Introduced in House
Plain-English summary
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1